Scientists reprogram Patient's own cells to fight spreading prostate cancer

NCT ID NCT06267729

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing a new treatment called AZD0754 for men whose prostate cancer has spread and is no longer responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to target a protein on cancer cells, and then infuse them back into the patient. The main goals are to see if this personalized cell therapy is safe and if it can reduce cancer activity and shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Duarte, California, 91010, United States
Research Site
RECRUITING

Tampa, Florida, 33612, United States
Research Site
RECRUITING

Atlanta, Georgia, 30322, United States
Research Site
NOT_YET_RECRUITING

Westwood, Kansas, 66205, United States
Research Site
NOT_YET_RECRUITING

Boston, Massachusetts, 02114, United States
Research Site
NOT_YET_RECRUITING

Boston, Massachusetts, 02215, United States
Research Site
RECRUITING

St Louis, Missouri, 63110, United States
Research Site
RECRUITING

Hackensack, New Jersey, 07601, United States
Research Site
RECRUITING

New York, New York, 10032, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Research Site
NOT_YET_RECRUITING

Dallas, Texas, 75235, United States
Research Site
RECRUITING

Houston, Texas, 77030, United States
Research Site
RECRUITING

East Melbourne, 3002, Australia
Research Site
NOT_YET_RECRUITING

Pamplona, 31008, Spain

Conditions

Explore the condition pages connected to this study.

METASTATIC PROSTATE CANCER